China SXT Pharmaceuticals, Inc. Contract Liability (Deferred Revenue)
China SXT Pharmaceuticals, Inc. (SXTC) had Contract Liability (Deferred Revenue) of $104.42 thousand as of 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-07-01
- 2026-03-31: Contract with Customer, Liability, Current $104.42K.
- 2025-09-30: Contract with Customer, Liability, Current $65.06K.
- 2025-03-31: Contract with Customer, Liability, Current $58.63K.
- 2024-09-30: Contract with Customer, Liability, Current $190.34K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-03-31 | $104.42K 20-F · filed 2026-07-01 |
| 2025-09-30 | $65.06K 6-K · filed 2025-12-31 |
| 2025-03-31 | $58.63K 20-F · filed 2026-07-01 |
| 2024-09-30 | $190.34K 6-K · filed 2025-03-28 |
| 2024-03-31 | $187.66K 20-F · filed 2026-07-01 |
| 2023-03-31 | $165.53K 20-F · filed 2025-07-31 |